Skip to content
Log in
  • Products
  • B2B Login
  • About us
  • News
  • Contact
  • Instagram
  • WhatsApp
Need help? call us +420 384 723 005
SOLOVYA®
  • Products
  • B2B Login
  • About us
  • News
  • Contact
Austria Log in €0,00 Total €0,00 in cart
Access Denied
IMPORTANT! If you’re a store owner, please make sure you have Customer accounts enabled in your Store Admin, as you have customer based locks set up with EasyLockdown app. Enable Customer Accounts

About us

  • 30K+
    Orders fullfilled
  • 24/7
    Support availability
  • 1000+
    Project's completed
  • 25mio
    Business volume

Solovya – A new chapter in the hemp industry

To create World’s finest cannabinoid experiences.

Become a partner
"Hemp is one of the most versatile and underestimated plants on this planet. At Solovya, we’re here to unlock its full potential – with vision, responsibility, and passion."
Vincent Popp
CEO & Founder

Our Milestones

  • 2021

    Founding of Solovya & strategic brand positioning

    Solovya is founded with a clear mission: to set a new standard in the hemp industry. From day one, our focus lies on quality, compliance, and long-term brand building across Europe.

  • 2022

    Establishment of Czech production site & scaling operations

    We open our first dedicated facility in the Czech Republic, expanding our production capacity and securing full control over manufacturing, sourcing, and quality assurance.

  • 2023

    European product launch & market expansion

    We successfully introduce our first line of premium hemp-based products across multiple EU markets. Solovya begins to establish itself as a trusted name in the cannabinoid industry.

  • 2024

    Innovation of proprietary cannabinoid formulations

    Solovya’s R&D team develops next-generation cannabinoid blends with enhanced bioavailability and stability. New product formats and applications are prepared for regulated markets.

  • 2025

    GMP-certified production & medical cannabis launch

    We establish a new GMP facility in Germany for pharmaceutical-grade raw materials. In Q4, Solovya obtains regulatory approval for medical cannabis in Germany and officially launches its first line of prescription-based products.

Our heads

  • Vincent Popp

    Chief Executive Officer (CEO)
  • Franziska Wunsch

    Chief Financial Officer (CFO)
  • Matthias Bednorz

    Chief Technology Officer (CTO)
  • Benjamin Popp

    Chief Growth Officer (CGO)
  • Ladislav Dudy-Koťo

    Chief Operating Officer (COO)
Invalid password
Enter
  • Menu

    • Products
    • B2B Login
    • About us
    • News
    • Contact

    Menu

    • Products
    • B2B Login
    • About us
    • News
    • Contact
  • About

    • Iimprint
    • Data protection
    • Right of withdrawal
    • Contact

    About

    • Iimprint
    • Data protection
    • Right of withdrawal
    • Contact
  • Contact

    info@solovya-labs.com
    +420 384 723 005
    • Instagram
    • WhatsApp
Localization
Payment methods
    © 2025, SOLOVYA® .
    • Refund policy
    • Privacy policy
    • Terms of service
    • Contact information
    • Legal notice

    Popular searches

    Keyboard Mouse Headset VR Wireless Mechanical RGB Ergonomic
    View cart

    Your cart is empty

    Continue shopping
    Have an account?
    Log in to check out faster.
    Country/region
    Austria | EUR €
    • Åland Islands Åland Islands(EUR €)
    • Albania Albania(EUR €)
    • Andorra Andorra(EUR €)
    • Austria Austria(EUR €)
    • Belarus Belarus(EUR €)
    • Belgium Belgium(EUR €)
    • Bosnia & Herzegovina Bosnia & Herzegovina(EUR €)
    • Bulgaria Bulgaria(EUR €)
    • Croatia Croatia(EUR €)
    • Czechia Czechia(EUR €)
    • Denmark Denmark(EUR €)
    • Estonia Estonia(EUR €)
    • Faroe Islands Faroe Islands(EUR €)
    • Finland Finland(EUR €)
    • France France(EUR €)
    • Germany Germany(EUR €)
    • Gibraltar Gibraltar(EUR €)
    • Greece Greece(EUR €)
    • Guernsey Guernsey(EUR €)
    • Hungary Hungary(EUR €)
    • Iceland Iceland(EUR €)
    • Ireland Ireland(EUR €)
    • Isle of Man Isle of Man(EUR €)
    • Italy Italy(EUR €)
    • Jersey Jersey(EUR €)
    • Latvia Latvia(EUR €)
    • Liechtenstein Liechtenstein(EUR €)
    • Lithuania Lithuania(EUR €)
    • Luxembourg Luxembourg(EUR €)
    • Malta Malta(EUR €)
    • Moldova Moldova(EUR €)
    • Monaco Monaco(EUR €)
    • Montenegro Montenegro(EUR €)
    • Netherlands Netherlands(EUR €)
    • North Macedonia North Macedonia(EUR €)
    • Norway Norway(EUR €)
    • Poland Poland(EUR €)
    • Portugal Portugal(EUR €)
    • Romania Romania(EUR €)
    • Russia Russia(EUR €)
    • San Marino San Marino(EUR €)
    • Serbia Serbia(EUR €)
    • Slovakia Slovakia(EUR €)
    • Slovenia Slovenia(EUR €)
    • Spain Spain(EUR €)
    • Svalbard & Jan Mayen Svalbard & Jan Mayen(EUR €)
    • Sweden Sweden(EUR €)
    • Switzerland Switzerland(EUR €)
    • Ukraine Ukraine(EUR €)
    • United Kingdom United Kingdom(EUR €)
    • Vatican City Vatican City(EUR €)
    View details

    Subscribe now

    Subscribe now and get 10% off your first purchase!

    • Instagram
    • WhatsApp
    Are you sure?
    • Choosing a selection results in a full page refresh.
    • Opens in a new window.